CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-17 | Fust Matthew K Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-03-12 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +1,000 | $0.94 | $940 | 10,100 |
| 2018-03-12 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −1,000 | $31.08 | $31K | 9,100 |
| 2018-03-12 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −1,000 | 20,497 | ||
| 2018-03-05 | Karrels James SVP, CFO and Secretary | Sale | −5,000 | $31.00 | $155K | 114,847 |
| 2018-03-05 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −4,000 | 21,497 | ||
| 2018-03-02 | Karrels James SVP, CFO and Secretary | Grant or award · Employee stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-02 | Peters Jeffrey Stuart Acting General Counsel | Grant or award · Employee stock option (right to buy) | +50,000 | 50,000 | ||
| 2018-03-02 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Employee stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-02 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +4,000 | $0.94 | $4K | 13,100 |
| 2018-03-02 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −4,000 | $30.00 | $120K | 9,100 |
| 2018-03-02 | Risser Eric Blasius Sr VP & Chief Business Officer | Grant or award · Employee stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-02 | Wigginton Jon Marc Sr VP, Clinical Dev. & CMO | Grant or award · Employee stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-02 | Koenig Scott President and CEO | Grant or award · Employee stock option (right to buy) | +225,000 | 225,000 | ||
| 2018-03-02 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Grant or award · Employee stock option (right to buy) | +50,000 | 50,000 | ||
| 2018-03-02 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Employee stock option (right to buy) | +28,000 | 28,000 | ||
| 2018-02-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +1,000 | $0.94 | $940 | 10,100 |
| 2018-02-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −1,000 | $25.01 | $25K | 9,100 |
| 2018-02-28 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −1,000 | 25,497 | ||
| 2018-02-28 | Cilinski Lynn VP, Controller and Treasurer | Exercise or conversion | +7,989 | $0.94 | $8K | 9,912 |
Page 32 of 35 · 684 trades